Recent political efforts to engage the Make America Health Again (MAHA) voting group appear unlikely to benefit the GOP in upcoming elections. The Trump administration’s outreach to this bloc resulted in the appointment of Robert F. Kennedy Jr. as Health and Human Services Secretary. A prominent Democrat in the past, Kennedy’s endorsement aimed to connect the GOP with new voters when Trump’s popularity was waning. Despite these efforts, there remains uncertainty about MAHA’s impact on the midterms.
Tony Lyons, closely associated with Kennedy, has initiated a $100 million fundraising campaign through the MAHA PAC. However, the first half of 2025 saw the committee spending $3.8 million, strictly on initiatives unrelated to candidates. Recent data shows the PAC has raised only $2.4 million, maintaining about $287,000 in cash reserves.
Political experts point out that MAHA voters supporting Trump might not support the GOP in midterms. Jeff Hutt, who previously worked with Kennedy’s presidential campaign and the PAC, emphasized that small donors were crucial to Kennedy’s campaign success, not predominantly Trump or GOP supporters. Hutt remarked, “They believed in Bobby Kennedy and what he was doing. Now without Kennedy, shifting focus to MAHA-branded Republicans might not spark the same interest.” He suggested that while MAHA may contribute to tight races, it is unlikely to significantly change electoral outcomes. GOP reliance on MAHA endorsements alone might prove inadequate.
This week’s healthcare sector updates include a federal judge postponing a lawsuit challenging the FDA’s approval of the abortion pill mifepristone until post-midterm elections. The Department of Justice requested this delay, which Judge Reed O’Connor approved, targeting December 1 or upon FDA’s review completion.
Additionally, the Trump administration revealed new Medicaid drug pricing deals with several biotech and pharmaceutical companies, promising the world’s lowest drug prices for state Medicaid programs. This initiative covers various outpatient drugs, asserting global economical pricing for the medications.
Environmental factors affecting public health are also in focus, particularly concerning Vibrio bacteria prevalent in warm coastal waters like Florida, potentially leading to severe illnesses. Vibrio has expanded to areas previously unaffected, coinciding with rising water temperatures.
On broader health issues, the federal probe into a lettuce-linked cyclospora outbreak has expanded to 20 states following additional cases confirmed in Georgia, Tennessee, and Texas. This marks the most extensive U.S. cyclosporiasis outbreak recorded.
Local healthcare news highlights include impacts of federal grant cuts on Colorado healthcare efficiency studies, inquiries into the DEA’s potential negligence in New Mexico’s fentanyl crisis, and Nevada’s rising vaccine exemptions among kindergarteners.
For further insights on health topics, notable coverage includes the Atlantic on a measles outbreak, Politico’s examination of RFK Jr.’s role in staffing federal jobs, and Stat’s commentary on mRNA advancements.